258 related articles for article (PubMed ID: 25450398)
21. Novel pharmacologic targeting of tight junctions and focal adhesions in prostate cancer cells.
Hensley PJ; Desiniotis A; Wang C; Stromberg A; Chen CS; Kyprianou N
PLoS One; 2014; 9(1):e86238. PubMed ID: 24497940
[TBL] [Abstract][Full Text] [Related]
22. suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion.
Piccolella M; Festuccia C; Millimaggi D; Locatelli A; Bologna M; Motta M; Dondi D
Int J Oncol; 2008 Jan; 32(1):185-91. PubMed ID: 18097558
[TBL] [Abstract][Full Text] [Related]
23. Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma.
Yan Q; Bach DQ; Gatla N; Sun P; Liu JW; Lu JY; Paller AS; Wang XQ
Mol Cancer Res; 2013 Jun; 11(6):665-75. PubMed ID: 23525268
[TBL] [Abstract][Full Text] [Related]
24. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
[TBL] [Abstract][Full Text] [Related]
25. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
Moreau M; Mourah S; Dosquet C
Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
[TBL] [Abstract][Full Text] [Related]
26. Myoferlin depletion elevates focal adhesion kinase and paxillin phosphorylation and enhances cell-matrix adhesion in breast cancer cells.
Blackstone BN; Li R; Ackerman WE; Ghadiali SN; Powell HM; Kniss DA
Am J Physiol Cell Physiol; 2015 Apr; 308(8):C642-9. PubMed ID: 25631868
[TBL] [Abstract][Full Text] [Related]
27. Gangliosides inhibit urokinase-type plasminogen activator (uPA)-dependent squamous carcinoma cell migration by preventing uPA receptor/alphabeta integrin/epidermal growth factor receptor interactions.
Wang XQ; Sun P; Paller AS
J Invest Dermatol; 2005 Apr; 124(4):839-48. PubMed ID: 15816844
[TBL] [Abstract][Full Text] [Related]
28. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
Mi Z; Guo H; Wai PY; Gao C; Kuo PC
Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of the urokinase receptor splice variant uPAR-del4/5 in breast cancer cells affects cell adhesion and invasion in a dose-dependent manner and modulates transcription of tumor-associated genes.
Grismayer B; Sato S; Kopitz C; Ries C; Soelch S; Schmitt M; Baretton G; Krüger A; Luther T; Kotzsch M; Magdolen V
Biol Chem; 2012 Dec; 393(12):1449-55. PubMed ID: 23667902
[TBL] [Abstract][Full Text] [Related]
30. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
[TBL] [Abstract][Full Text] [Related]
31. The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model.
King TE; Pawar SC; Majuta L; Sroka IC; Wynn D; Demetriou MC; Nagle RB; Porreca F; Cress AE
PLoS One; 2008; 3(10):e3535. PubMed ID: 18958175
[TBL] [Abstract][Full Text] [Related]
32. Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression.
Ghosh S; Koblinski J; Johnson J; Liu Y; Ericsson A; Davis JW; Shi Z; Ravosa MJ; Crawford S; Frazier S; Stack MS
Mol Cancer Res; 2010 Feb; 8(2):145-58. PubMed ID: 20145038
[TBL] [Abstract][Full Text] [Related]
33. Differences in integrin expression and signaling within human breast cancer cells.
Taherian A; Li X; Liu Y; Haas TA
BMC Cancer; 2011 Jul; 11():293. PubMed ID: 21752268
[TBL] [Abstract][Full Text] [Related]
34. Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.
Thomas S; Chiriva-Internati M; Shah GV
Clin Exp Metastasis; 2007; 24(5):363-77. PubMed ID: 17487556
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of cathepsin B and uPAR inhibits CD151 and α3β1 integrin-mediated cell adhesion and invasion in glioma.
Rao Malla R; Gopinath S; Alapati K; Gorantla B; Gondi CS; Rao JS
Mol Carcinog; 2013 Oct; 52(10):777-90. PubMed ID: 22495828
[TBL] [Abstract][Full Text] [Related]
36. Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.
Bellance C; Khan JA; Meduri G; Guiochon-Mantel A; Lombès M; Loosfelt H
Mol Biol Cell; 2013 May; 24(9):1363-74. PubMed ID: 23485561
[TBL] [Abstract][Full Text] [Related]
37. Integrin alpha6 cleavage: a novel modification to modulate cell migration.
Pawar SC; Demetriou MC; Nagle RB; Bowden GT; Cress AE
Exp Cell Res; 2007 Apr; 313(6):1080-9. PubMed ID: 17303120
[TBL] [Abstract][Full Text] [Related]
38. Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells.
Jo M; Eastman BM; Webb DL; Stoletov K; Klemke R; Gonias SL
Cancer Res; 2010 Nov; 70(21):8948-58. PubMed ID: 20940399
[TBL] [Abstract][Full Text] [Related]
39. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
40. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]